TrialRadiation oncology (London, England)2018

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up.

Marta Scorsetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.